Ethyl 2,2-difluoro-2-(3-fluorophenyl)acetate, 95.0%, 1g

1-CYCLOPROPYLHYDRAZINE 2HCL, 95.0%, 250mg

6,7-Dimethyl-4-chromanone, 95.0%, 250mg

3-Bromo-5-nitrobenzaldehyde>96.0%(GC)1g

2-Fluoro-3-(trifluoromethoxy)aniline, 95.0%, 100g

ETHYL 6-BROMOPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLATE, 95.0%, 250mg

GC capillary column ROTI®Cap-5, 15 m, 0.25 mm, 0.25 µm, 1 Piece(s)

3,4-Dimethylbenzenesulfonamide, 97.0%, 250mg

4-Chloro-3-iodo-1H-pyrazolo[3,4-b]pyridine, 95.0%, 250mg

(R)-4-methyl-N-((R)-1-(((R)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide, 98%, 10mg

3,5-Dichloro-4-(trifluoromethyl)pyridine, 98%, 1g

Dibenzofuran-2-carboxaldehyde, 95.0%, 1g

2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4'-methoxy benzophenone, 97.0%, 1g